After two years of vastly underperforming the overall market, last week the biotech sector rose some 10% in its best weekly performance in several years. In so doing, the major biotech indices crashed through upward resistance levels that had been firmly in place since the very end of 2015. Even after the rally, biotech is some 20% below its previous peak in July of 2015.
